Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2023-02-01 12:31 pm Purchase | 13G | XPONENTIAL FITNESS INC CL XPOF | FEDERATED HERMES INC. FHI | 1,875,000 6.8% | 475,000 (+33.93%) | View |
2023-02-01 12:24 pm Purchase | 13G | SOUNDTHINKING, INC. SSTI | FEDERATED HERMES INC. FHI | 1,320,594 10.83% | 1,197,094 (+969.31%) | View |
2023-02-01 12:15 pm Purchase | 13G | SERES THERAPEUTICS INC MCRB | FEDERATED HERMES INC. FHI | 18,085,938 14.52% | 103,682 (+0.58%) | View |
2023-02-01 12:05 pm Purchase | 13G | SCYNEXIS INC SCYX | FEDERATED HERMES INC. FHI | 6,866,914 19.99% | 6,866,914 (New Position) | View |
2023-02-01 11:57 am Purchase | 13G | RHYTHM PHARMACEUTICALS INC RYTM | FEDERATED HERMES INC. FHI | 6,304,482 11.19% | 1,239,369 (+24.47%) | View |
2023-02-01 11:50 am Purchase | 13G | REZOLUTE INC RZLT | FEDERATED HERMES INC. FHI | 7,550,274 19.99% | 4,361,052 (+136.74%) | View |
2023-02-01 11:43 am Sale | 13G | REGULUS THERAPEUTICS INC RGLS | FEDERATED HERMES INC. FHI | 2,904,826 17.25% | -26,143,439 (-90.00%) | View |
2023-02-01 11:34 am Purchase | 13G | P10 INC PX | FEDERATED HERMES INC. FHI | 3,181,933 7.78% | 359,073 (+12.72%) | View |
2023-02-01 11:25 am Purchase | 13G | ORCHARD THERAPEUTICS PLC ADS ORTX | FEDERATED HERMES INC. FHI | 8,401,687 6.63% | 91,828 (+1.11%) | View |
2023-02-01 11:16 am Purchase | 13G | MINERVA NEUROSCIENCES INC NERV | FEDERATED HERMES INC. FHI | 1,201,275 22.5% | 1,201,275 (New Position) | View |
2023-02-01 11:06 am Purchase | 13G | MERUS N V COM MRUS | FEDERATED HERMES INC. FHI | 3,924,295 8.48% | 244,995 (+6.66%) | View |
2023-02-01 10:58 am Purchase | 13G | IDEAYA BIOSCIENCES INC IDYA | FEDERATED HERMES INC. FHI | 2,864,500 5.95% | 574,218 (+25.07%) | View |
2023-02-01 10:46 am Sale | 13G | DYNAVAX TECHNOLOGIES CORP COM DVAX | FEDERATED HERMES INC. FHI | 12,640,363 9.91% | -4,142,475 (-24.68%) | View |
2023-02-01 10:39 am Purchase | 13G | CASI PHARMACEUTICALS INC CASI | FEDERATED HERMES INC. FHI | 900,651 6.62% | 900,651 (New Position) | View |
2023-02-01 10:29 am Purchase | 13G | ATYR PHARMA INC LIFE | FEDERATED HERMES INC. FHI | 5,231,600 18.03% | 5,231,600 (New Position) | View |
2023-02-01 10:21 am Unchanged | 13G | ARIS WTR SOLUTIONS INC ARIS | FEDERATED HERMES INC. FHI | 2,588,600 9.76% | 0 (Unchanged) | View |
2023-02-01 10:11 am Purchase | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | FEDERATED HERMES INC. FHI | 4,239,554 16% | 544,625 (+14.74%) | View |
2023-02-01 10:07 am Purchase | 13G | ANNEXON INC ANNX | FEDERATED HERMES INC. FHI | 3,057,800 6.42% | 1,032,200 (+50.96%) | View |
2023-02-01 09:49 am Purchase | 13G | ANAPTYSBIO INC ANAB | FEDERATED HERMES INC. FHI | 2,373,023 8.35% | 1,053,850 (+79.89%) | View |
2023-02-01 09:43 am Sale | 13G | AMPHASTAR PHARMACEUTICALS INC AMPH | FEDERATED HERMES INC. FHI | 3,284,217 6.8% | -180,118 (-5.20%) | View |